MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 71486 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 NIVOLUMAB 8153
1 PEMBROLIZUMAB 5933
2 ENZALUTAMIDE 4878
3 EVEROLIMUS 4027
4 CARBOPLATIN 3801
5 IPILIMUMAB 3125
6 CAPECITABINE 2894
7 LETROZOLE 2852
8 FULVESTRANT 2650
9 PACLITAXEL 2622
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFATINIB 1515 0.2633
1 GEFITINIB 1560 0.1917
2 CERITINIB 398 0.1838
3 PRALATREXATE 95 0.1789
4 RUCAPARIB 1111 0.1479
5 RAMUCIRUMAB 623 0.1389
6 PEMBROLIZUMAB 5933 0.1375
7 OLAPARIB 1320 0.1362
8 STREPTOZOCIN 20 0.1342
9 FULVESTRANT 2650 0.1258
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION